Cancer Research Center Signs Multiyear Commitment to OmniComm’s TrialMaster EDC


Applied Clinical Trials

A clinical research center signs a $3.5 Million commitment to TrialMaster EDC and OmniComm Systems, Inc., a global provider of clinical data management technology in hopes to use TrialMaster EDC for clinical data collection to develop patient-centric cancer therapies.

Read the full release here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.